Priya Kumthekar

Also affiliated with Northwestern Medicine

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Discordance between central versus local response assessments in neuroendocrine tumor (NET) patients (pts) enrolled in A021202.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.361

Top 100%

0DataRank

Top 100%0 citations

Michelle R. Mahoney, Timothy R. Asmis, Nathan C. Hall, Sanja Karovic, Michael V. Knopp +9 more

Papers

Driven by 35 papers — median percentile 0. Top paper: “BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas”.

BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

New England Journal of Medicine(2023)10.1056/nejmoa2213329

N/A

4.5DataRank · unranked

138 citations

Erin Twohy, Susan Geyer, Elizabeth R. Gerstner, Timothy J. Kaufmann, Shervin Tabrizi +23 more

Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial

The Lancet Oncology(2021)10.1016/s1470-2045(21)00245-x

N/A

3.7DataRank · unranked

212 citations

Atique U. Ahmed, Ilya V. Ulasov, Adam M. Sonabend, Jason Miska, Catalina Lee-Chang +22 more

Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial

The Lancet Oncology(2023)10.1016/s1470-2045(23)00112-2

N/A

3.6DataRank · unranked

234 citations

Andrew Gould, Christina Amidei, Rachel Ward, Karyn A Schmidt, Daniel Y. Zhang +17 more

Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions

Neuro-Oncology(2022)10.1093/neuonc/noac118

N/A

3.5DataRank · unranked

197 citations

Nayan Lamba, Manmeet S. Ahluwalia, Kenneth Aldape, Adrienne Boire, Priscilla K. Brastianos +20 more

Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer

Journal of Neuro-Oncology(2020)10.1007/s11060-020-03555-z

N/A

1.9DataRank · unranked

82 citations

Martin Fleisher, Priya Kumthekar, Xuling Lin, Antonio Omuro, Morris D. Groves +12 more

Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2502

N/A

0.964DataRank · unranked

24 citations

Erin Twohy, Elizabeth R. Gerstner, Timothy J. Kaufmann, A. John Iafrate, Suriya Jeyapalan +16 more

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network(2020)10.6004/jnccn.2020.0052

N/A

0.953DataRank · unranked

575 citations

Jana Portnow, Manmeet S. Ahluwalia, Joachim M. Baehring, Henry Brem, Steven Brem +30 more

A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma

Science Translational Medicine(2021)10.1126/scitranslmed.abb3945

N/A

0.870DataRank · unranked

329 citations

Caroline H. Ko, Tatjana Paunesku, Karan Dixit, Adam M. Sonabend, Orin Bloch +32 more

Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3874

N/A

0.706DataRank · unranked

110 citations

Lijie Zhai, Kristen L. Lauing, April Bell, Jiahui Xu, Masha Kocherginsky +20 more

Glioblastoma as an age-related neurological disorder in adults

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab125

N/A

0.705DataRank · unranked

109 citations

Erik Ladomersky, Andreas Mozny, Masha Kocherginsky, Kaitlyn O’Shea, Zachary Z. Reinstein +25 more

A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics

Neuro-Oncology(2022)10.1093/neuonc/noac195

N/A

0.663DataRank · unranked

82 citations

Michael J. Avram, Andrew B. Lassman, Nancy U. Lin, Eudocia Q. Lee, Sean Grimm +13 more

Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

Nature Medicine(2023)10.1038/s41591-023-02464-8

N/A

0.604DataRank · unranked

55 citations

Kelly Hotchkiss, Ian F. Parney, John de Groot, Solmaz Sahebjam, Nader Sanai +31 more

Neurologic Manifestations of Long COVID Differ Based on Acute COVID‐19 Severity

Annals of Neurology(2023)10.1002/ana.26649

N/A

0.596DataRank · unranked

52 citations

Sareen T. Ali, Anthony K. Kang, Tulsi R. Patel, Shreya Budhiraja, Jordan I. Gaelen +29 more

Phase II trial of blood–brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma

Neuro-Oncology Advances(2024)10.1093/noajnl/vdae186

N/A

0.574DataRank · unranked

17 citations

Andrew Brenner, David Piccioni, Patrick Y Wen, Jan Drappatz, Maciej Mrugala +10 more

CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease

Frontiers in Immunology(2021)10.3389/fimmu.2021.745893

N/A

0.462DataRank · unranked

9 citations

Anantha Marisetty, Craig Horbinski, James P. Long, Jason T. Huse, I. C. Glitza +8 more

Alliance A071601: Phase II trial of BRAF/MEK inhibition in newly diagnosed papillary craniopharyngiomas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2000

N/A

0.457DataRank · unranked

20 citations

Erin Twohy, Susan Geyer, Elizabeth R. Gerstner, Timothy J. Kaufmann, Michael W. Ruff +15 more

Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0447

N/A

0.360DataRank · unranked

10 citations

Chao Ma, Chen Yuan, Qian Shi, Brian M. Wolpin, Yin Zhang +19 more

Multi-center, single arm phase II study of the dual mTORC1/mTORC2 inhibitor vistusertib for patients with recurrent or progressive grade II-III meningiomas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2024

N/A

0.345DataRank · unranked

9 citations

Priya Kumthekar, Patrick Y. Wen, Frederick G. Barker, Anat Stemmer‐Rachamimov, Roberta L. Beauchamp +4 more

Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4003

N/A

0.217DataRank · unranked

3 citations

Qian Shi, Charles S. Fuchs, Donna Niedzwiecki, Tyler Zemla, Priya Kumthekar +15 more

CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Cancer Research Communications(2024)10.1158/2767-9764.crc-22-0516

N/A

0.216DataRank · unranked

2 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Priya Kumthekar +16 more

Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205

Research Square(2025)10.21203/rs.3.rs-7567487/v1

N/A

0DataRank · unranked

0 citations

Rimas V. Lukas, Lijie Zhai, Kristen L. Lauing, Miri Kim, Taylor Koch +25 more

Alliance A071701: Genomically guided treatment trial in brain metastases.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps2573

N/A

0DataRank · unranked

7 citations

Erin Twohy, Carey K. Anders, A. John Iafrate, Peter A. Kaufman, Justine V. Cohen +11 more

Advances in the diagnosis, evaluation, and management of leptomeningeal disease

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab108

N/A

0DataRank · unranked

29 citations

Priya Kumthekar, Adrienne Boire, Uğur Sener

Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab186

N/A

0DataRank · unranked

4 citations

Claudia R. Oliva, Christopher S. Coffey, Merit Cudkowicz, Robin Conwit, Anna Gudjonsdottir +28 more

Discordance between central versus local response assessments in neuroendocrine tumor (NET) patients (pts) enrolled in A021202.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.361

Top 100%

0DataRank

Top 100%0 citations

Michelle R. Mahoney, Timothy R. Asmis, Nathan C. Hall, Sanja Karovic, Michael V. Knopp +9 more

Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac041

N/A

0DataRank · unranked

10 citations

S. Keith Anderson, Erin Twohy, Nicholas Butowski, Adı́lia Hormigo, David Schiff +11 more

Preclinical modeling in leptomeningeal disease: Starting at the foundation to tackle a difficult disease

Neuro-Oncology(2022)10.1093/neuonc/noac142

N/A

0DataRank · unranked

1 citations

Seema Nagpal, Priya Kumthekar

Randomized phase II/III trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed glioblastoma (GBM) patients with MGMT promoter hypermethylation (Alliance A071102).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2001

N/A

0DataRank · unranked

18 citations

Karla V. Ballman, Sani H. Kizilbash, Erik P. Sulman, Caterina Giannini, Sandeep H. Mashru +11 more

Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results

Acta Neuropathologica Communications(2023)10.1186/s40478-023-01680-0

N/A

0DataRank · unranked

4 citations

Pouya Jamshidi, Vineeth Thirunavu, Lucas Santana‐Santos, Erica Vormittag‐Nocito, David J. Dittman +15 more

Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions

Neuro-Oncology(2024)10.1093/neuonc/noae103

N/A

0DataRank · unranked

61 citations

Ugonma Chukwueke, Myung‐Ju Ahn, Ayal A. Aizer, Tejus Bale, Dieta Brandsma +24 more

Clinical outcomes for pleomorphic xanthoastrocytoma patients

Neuro-Oncology Practice(2024)10.1093/nop/npae074

N/A

0DataRank · unranked

1 citations

James P. Chandler, Maciej S. Lesniak, Matthew C. Tate, Adam M. Sonabend, John A. Kalapurakal +5 more

Retrospective Review of Intra-Cerebrospinal Fluid (CSF) Drug Delivery in CNS Malignancies: Safety, Clinical Efficacy and Pharmacokinetic Profiles of Intracerebroventricular (ICV), Lumbar Intrathecal (LIT), and Intra-Cisterna Magna (ICM) Injections

Cancers(2025)10.3390/cancers17081263

N/A

0DataRank · unranked

10 citations

Marcie A. Glicksman, Rajan Patel, Saaz Malhotra, Nathan Moelis, Nisheka N. Vanjani +2 more

Dynamic release of extracellular particles after opening of the blood-brain barrier predicts glioblastoma susceptibility to paclitaxel

Nature Communications(2025)10.1038/s41467-025-65681-4

N/A

0DataRank · unranked

7 citations

Abha Kumari, Yoon‐Tae Kang, Andrew Gould, Karl J. Habashy, Mateo Gomez +25 more

Beyond the brain: exploring the impact of animal models of leptomeningeal disease from solid tumors

Acta Neuropathologica Communications(2025)10.1186/s40478-025-01959-4

N/A

0DataRank · unranked

5 citations

Priya Kumthekar, Atique U. Ahmed, Jillyn R. Turunen

Consortium for Intracranial Metastasis Academic Research (CIMARa): Global interdisciplinary collaborations to improve outcomes of patients with brain metastases

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf049

N/A

0DataRank · unranked

2 citations

Amanda E.D. Van Swearingen, Josh Neman, Johanna A. Joyce, Diana M. Cittelly, Manuel Valiente +17 more

Priya Kumthekar

Indexed papers

Top data-sharing exemplar

Papers